[关键词]
[摘要]
自2019年12月以来,国内外暴发了新型冠状病毒肺炎(COVID-19)。在COVID-19的患者中,除了抗病毒治疗外,还要治疗并发症,临床需要采取联合用药的方式进行治疗。虽然在近期发布的指南中多次强调注意抗COVID-19药物间的相互作用,但却无相应的详述。主要对治疗COVID-19药物的潜在相互作用进行综述,以期为COVID-19的临床安全、合理用药提供参考。
[Key word]
[Abstract]
From the December 2019, coronavirus disease 2019 (COVID-19) was outbreak at home and abroad. Besides antiviral therapy, patients should be treated for complications, therefore a combination of drugs for treatment in clinic need to be taken. Although recently published guidelines have repeatedly highlighted the drug interactions between the anti-COVID-19 medicines, it has not been detailed. The potential drug-drug interactions were reviewed of the anti-COVID-19 drugs, and in order to provide references for the clinical safety and rational use of the anti-COVID-19 drugs.
[中图分类号]
R969.2
[基金项目]
贵州省科技支撑项目(黔科合支撑[2020]4Y118号);贵州省毕节市第一人民医院院士工作站项目(黔科合平台人才[2018]55621-7);毕节市科技局重点实验室项目(毕科合字[2019]1号);毕节市医学重点学科项目(毕卫合字[2016]1)